for preparing gels. in the innovation salon, st. petersburg. last year we received this development together with belmedpreparations and the republican scientific and political center for medical oncology alexandrova well, the main developer and holder, e patent and licensed because this drug is registered by seventy-two third parties of the world. let's try god's grand prix salons of the international salon of innovation. that's why drugs, these key clinical protocols of treatment, are still purchased by the state order in the republic of belarus . how much does this permission allow us to save money? well, if you just look at, uh, last year. uh, exactly, if the republic of belarus would acquire, uh, an analogue of american eyes, it costs about 15,000 us dollars, then import substitution parts even here, the savings in foreign currency amounted to about 3 million us dollars only on e, we plan to enter foreign markets for these two drugs. now let's say that doctors from colombia were taking it now and it is planned and, let's say, such a shipment of this drug there and registration processes are underway. and the european union, so now we are working on dossier. we bring the correspondence in order to